1. Bullous pemphigoid associated with nivolumab, a programmed cell death 1 protein inhibitor. (3rd March 2017) Authors: Kwon, C.W.; Land, A.S.; Smoller, B.R.; Scott, G.; Beck, L.A.; Mercurio, M.G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 8(2017) Page Start: e349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗